Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-049978
Filing Date
2020-04-23
Accepted
2020-04-23 07:36:39
Documents
5
Effectiveness Date
2020-04-23

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2015427d2_defa14a.htm DEFA14A 22220
2 GRAPHIC tm2015427d2_defa14a-img01.jpg GRAPHIC 213480
3 GRAPHIC tm2015427d2_defa14a-img02.jpg GRAPHIC 304903
4 GRAPHIC tm2015427d2_defa14a-img03.jpg GRAPHIC 136608
5 GRAPHIC tm2015427d2_defa14a-img04.jpg GRAPHIC 14033
  Complete submission text file 0001104659-20-049978.txt   945477
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-31812 | Film No.: 20809195
SIC: 2834 Pharmaceutical Preparations